These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 21372503)
21. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. de Boer HD; Driessen JJ; van Egmond J; Booij LH Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072 [No Abstract] [Full Text] [Related]
22. Reversal of neuromuscular blockade by sugammadex does not affect EEG derived indices of depth of anesthesia. Illman H; Antila H; Olkkola KT J Clin Monit Comput; 2010 Oct; 24(5):371-6. PubMed ID: 20734116 [TBL] [Abstract][Full Text] [Related]
23. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients]. Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333 [TBL] [Abstract][Full Text] [Related]
24. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265 [TBL] [Abstract][Full Text] [Related]
25. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report. Kim JE; Chun HR Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578 [TBL] [Abstract][Full Text] [Related]
26. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Groudine SB; Soto R; Lien C; Drover D; Roberts K Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208 [TBL] [Abstract][Full Text] [Related]
27. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope]. Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289 [No Abstract] [Full Text] [Related]
28. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal. Porter MV; Paleologos MS Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682 [TBL] [Abstract][Full Text] [Related]
29. Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome). Vilela H; Santos J; Colaço J; Oliveira E; Canas-da-Silva P J Anesth; 2012 Apr; 26(2):306-7. PubMed ID: 22198219 [No Abstract] [Full Text] [Related]
30. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699 [TBL] [Abstract][Full Text] [Related]
31. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring. Fabregat López J; Porta Vila G; Martin-Flores M Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256 [TBL] [Abstract][Full Text] [Related]
32. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888 [TBL] [Abstract][Full Text] [Related]
33. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex]. Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811 [TBL] [Abstract][Full Text] [Related]
34. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia. Donati F Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711 [TBL] [Abstract][Full Text] [Related]
35. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium. Yamamoto H; Uchida T; Yamamoto Y; Ito Y; Makita K J Anesth; 2011 Dec; 25(6):845-9. PubMed ID: 21935686 [TBL] [Abstract][Full Text] [Related]
38. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940 [TBL] [Abstract][Full Text] [Related]
39. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block. Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126 [TBL] [Abstract][Full Text] [Related]
40. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis]. Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]